Cancer Immunotherapy: A Focus on the Regulation of Immune Checkpoints.

about

Cancer Immunotherapy: A Focus on the Regulation of Immune Checkpoints.

Item

http://www.wikidata.org/entity/Q54218762

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Cancer Immunotherapy: A Focus on the Regulation of Immune Checkpoints.

@en

Cancer Immunotherapy: A Focus on the Regulation of Immune Checkpoints.

@nl

type

Item

label

Cancer Immunotherapy: A Focus on the Regulation of Immune Checkpoints.

@en

Cancer Immunotherapy: A Focus on the Regulation of Immune Checkpoints.

@nl

prefLabel

Cancer Immunotherapy: A Focus on the Regulation of Immune Checkpoints.

@en

Cancer Immunotherapy: A Focus on the Regulation of Immune Checkpoints.

@nl

P1476

Cancer Immunotherapy: A Focus on the Regulation of Immune Checkpoints

@en

P2093

Jiaxuan Jiang

http://www.w3.org/2001/XMLSchema#string

Lingfeng Yu

http://www.w3.org/2001/XMLSchema#string

Sunan Shen

http://www.w3.org/2001/XMLSchema#string

Tingting Wang

http://www.w3.org/2001/XMLSchema#string

Yanyu Ma

http://www.w3.org/2001/XMLSchema#string

Yayi Hou

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution

P2860

Oncolytic viruses as therapeutic cancer vaccines

The immunoreceptor TIGIT regulates antitumor and antiviral CD8(+) T cell effector function

The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells

The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity

Ipilimumab: an anti-CTLA-4 antibody for metastatic melanoma

Effector and memory T cell responses to commensal bacteria

CCL2-induced chemokine cascade promotes breast cancer metastasis by enhancing retention of metastasis-associated macrophages

CTLA-4 and PD-1/PD-L1 blockade: new immunotherapeutic modalities with durable clinical benefit in melanoma patients.

Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints.

Control of regulatory T cell development by the transcription factor Foxp3

P31

scholarly article

P356

10.3390/IJMS19051389

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Tao Shi

P5008

ScienceSource

P577

2018-05-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29735917

http://www.w3.org/2001/XMLSchema#string

P921

Aillse

immunotherapy

P932

5983802

http://www.w3.org/2001/XMLSchema#string